ArticleNature communications2018

Co-activation of super-enhancer-driven CCAT1 by TP63 and SOX2 promotes squamous cancer progression.

Yuan Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.